China has fundamentally reshaped the global pharmaceutical landscape through a series of aggressive pricing reforms that have seen the cost of life-saving medicines plummet by an average of 60% to 70%.
China has fundamentally reshaped the global pharmaceutical landscape through a series of aggressive pricing reforms that have seen the cost of life-saving medicines plummet by an average of 60% to 70%.